Cholesterol-Absorber Status Modifies the LDL Cholesterol-Lowering Effect of a Mediterranean-Type Diet in Adults with Moderate Cardiovascular Risk Factors

被引:5
|
作者
Wolff, Estelle [1 ,2 ]
Vergnes, Marie-France [1 ]
Portugal, Henri [1 ,2 ]
Defoort, Catherine [1 ]
Amiot-Carlin, Marie-Jo [1 ]
Lairon, Denis [1 ]
Nicolay, Alain [1 ,2 ]
机构
[1] INRA, UMR1260, Marseille, France
[2] Fac Med & Pharm IPHM IFR 125, INSERM Nutriments Lipid & Prevent Malad Metab ERL, Marseille, France
来源
JOURNAL OF NUTRITION | 2011年 / 141卷 / 10期
关键词
EPIC-NORFOLK POPULATION; SERUM PLANT STEROLS; MEDI-RIVAGE; NONCHOLESTEROL STEROLS; SURROGATE MARKERS; PLASMA-LEVELS; ABSORPTION; METABOLISM; PHYTOSTEROLS; FAT;
D O I
10.3945/jn.111.141333
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
LDL-cholesterol (LDL-C) reduction may be achieved by various types of prudent diets, but their effects on surrogate markers of cholesterol absorption and synthesis have not been well studied in humans. We aimed to assess whether the extent of cholesterol absorption or synthesis, and cholesterol concentrations, are modified in adults when they shift from a Western-type diet (WD) to a combined low-fat, low-cholesterol/Mediterranean-type diet (LFCMD). Cholestanol and sitosterol, as well as desmosterol and lathosterol, surrogate markers of cholesterol absorption or synthesis, respectively, were quantified in the serum of 125 fasting, middle-aged participants at moderate cardiovascular risk. They habitually consumed a WD and then consumed a LFCMD during the 3-mo intervention. The group was stratified by serum cholestanol concentration and classified as high, intermediate, or low absorbers of cholesterol. When they consumed the WD, participants had comparable total and LDL-C concentrations, independent of absorber group and sex. After 3 mo of consuming the LFCMD, absorption and synthesis did not change or changed only slightly. The cholestanol concentration increased in low absorbers by 18% (P < 0.02) and decreased in high absorbers by 14% (P < 0.001), but these variations did not change the high- or low-absorber status. In male and female low absorbers, plasma total (-7%) and LDL-C (-9%) concentrations decreased after the 3-mo intervention and changes were 2.3- and 2.4-fold greater, respectively, than in high absorbers, independent of sex. Cholesterol synthesis/absorption status was not markedly altered by diet, but the decrease in plasma LDL-C due to the Mediterranean-type diet occurred only in low absorbers of cholesterol. This should be considered during further dietary interventions. J. Nutr. 141: 1791-1798, 2011.
引用
收藏
页码:1791 / 1798
页数:8
相关论文
共 25 条
  • [1] Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk
    Figorilli, Filippo
    Mannarino, Massimo R.
    Bianconi, Vanessa
    Pirro, Matteo
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (04) : 327 - 336
  • [2] Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk
    Filippo Figorilli
    Massimo R. Mannarino
    Vanessa Bianconi
    Matteo Pirro
    High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 327 - 336
  • [3] Risk factors for stroke and the effect of cholesterol-lowering therapy with pravastatin
    West, M
    White, H
    Simes, R
    Kirby, A
    Anderson, N
    Hankey, G
    Tonkin, A
    JOURNAL OF HYPERTENSION, 2000, 18 : S17 - S17
  • [4] EFFECT OF APOLIPOPROTEIN-E PHENOTYPE ON DIET-INDUCED LDL CHOLESTEROL-LOWERING
    ORDOVAS, JM
    LOPEZMIRANDA, J
    MATA, P
    LICHTENSTEIN, AH
    CLEVIDENCE, B
    JUDD, JT
    DENKE, MA
    SCHAEFER, EJ
    FASEB JOURNAL, 1994, 8 (04): : A543 - A543
  • [5] EFFICACY OF AN NCEP STEP-2 DIET IN LDL CHOLESTEROL-LOWERING IN ELDERLY SUBJECTS WITH MODERATE HYPERCHOLESTEROLEMIA
    SCHAEFER, EJ
    LICHTENSTEIN, AH
    MCNAMARA, JR
    CONTOIS, J
    RASMUSSEN, H
    ORDOVAS, JM
    FASEB JOURNAL, 1994, 8 (04): : A452 - A452
  • [6] Coronary heart disease risk factors and LDL cholesterol-lowering efficacy of fibrates and simvastatin
    Muls, E
    Autier, P
    Malbecq, W
    Vansant, G
    CLINICAL DRUG INVESTIGATION, 1997, 14 (02) : 98 - 108
  • [7] Coronary Heart Disease Risk Factors and LDL Cholesterol-Lowering Efficacy of Fibrates and Simvastatin
    Erik Muls
    Philippe Autier
    William Malbecq
    Greet Vansant
    Clinical Drug Investigation, 1997, 14 : 98 - 108
  • [8] Effects of a cholesterol-lowering diet during pregnancy on cardiovascular risk factors and pregnancy outcome: A randomized clinical trial
    Khoury, J.
    Henriksen, T.
    Seljeflot, I.
    Christophersen, B.
    Morderid, L.
    Froslie, K. Fey
    Tonstad, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 126 - 126
  • [9] The Effect of an Education Program on Outcome Expectancy to Adhere to a Cholesterol-Lowering Diet in Adults with Hyperlipidemia presented by
    Musacchio-Acito, Michele
    NURSING RESEARCH, 2021, 70 (03) : E143 - E144
  • [10] Mediterranean diet supplemented with cholesterol-lowering foods and health-related quality of life in adults with HIV infection
    Ferreira, T.
    Stradling, C.
    Thomas, G. N.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2017, 76 (OCE1) : E9 - E9